You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 7, July 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Dermatology
 •Genetics of Head & Neck Disease
 •Neoplasms of Head & Neck
 •Melanoma
 •Alert me on articles by topic

L-myc Polymorphism in Head and Neck Nonmelanoma Skin and Lower Lip Cancers

Aydin Gözü, MD; Arzu Ergen, PhD; Deniz Dayicioglu, MD; Ilhan Yaylim, PhD; Zafer Özsoy, MD; Turgay Isbir, PhD

Arch Otolaryngol Head Neck Surg. 2008;134(7):725-728.

Objective  To evaluate the presence of L-myc gene variations as a genetic predisposition to head and neck nonmelanoma skin cancer (HNNMSC) and lower lip cancer (LLC).

Design  A case-control study.

Setting  An academic institute laboratory.

Participants  Twenty-four patients with HNNMSC and 27 with LLC were compared with 51 age- and sex-matched control subjects.

Main Outcome Measures  Polymerase chain reaction restriction fragment length polymorphism and agarose gel electrophoresis were used to determine the L-myc oncogene genotypes.

Results  The presence of the LS genotype was found to be significantly increased in the study group, whereas the LL genotype was not detected. The S allele was also more frequent in the study group. The SS genotype was found to correlate with aggressive tumor behavior in patients with HNNMSC and a family history of cancer. Patients with LLC displayed significantly less of the SS genotype.

Conclusions  The L-myc gene polymorphism may help detect and prevent HNNMSC and LLC in susceptible individuals. It may also contribute to estimation of tumor behavior in patients with HNNMSC.


Author Affiliations: Department of Plastic and Reconstructive Surgery, Vakif Gureba Research and Education Hospital (Drs Gözü, Dayicioglu, and Özsoy), and Institute of Experimental Medical Research, Department of Molecular Medicine, Istanbul University (Drs Ergen, Yaylim, and Isbir), Istanbul, Turkey.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.